Biostar Pharmaceuticals Inc BSPM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.01
- Bid/Ask
- $0.01 / $0.10
- Market Cap
- $263.72
- Volume/Avg
- 715 / 5,107
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Biostar Pharmaceuticals Inc through its subsidiaries involves in the development, manufacturing, and marketing of pharmaceutical products for a variety of diseases and conditions in the People's Republic of China where it generates most of its revenues. The company's products include Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter (OTC) medicine for chronic hepatitis B. The current product line of the company also includes several other OTC products and approximately 15 prescription-based pharmaceuticals. Its products are derived from medicinal herbs that are either grown at its own facility or purchased from the suppliers.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 200
Valuation
|
Metric
|
BSPM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
BSPM
Financial Strength
|
Metric
|
BSPM
|
|---|---|
Quick Ratio | 0.16 |
Current Ratio | 0.19 |
Interest Coverage | 18.81 |
Quick Ratio
BSPM
Profitability
|
Metric
|
BSPM
|
|---|---|
Return on Assets (Normalized) | 1.58% |
Return on Equity (Normalized) | 1.83% |
Return on Invested Capital (Normalized) | 2.02% |
Return on Assets
BSPM
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Szkvxtwmk | Bfwnw | $71.2 Bil | |
ZTS
| Zoetis Inc Class A | Wpfpzwdrsf | Dcyhl | $68.3 Bil | |
HLN
| Haleon PLC ADR | Zwstnlcvf | Tmxdn | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Fctndgf | Tksc | $14.5 Bil | |
VTRS
| Viatris Inc | Ffktzsfx | Dklj | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Pwjtykqv | Tmnn | $11.9 Bil | |
CTLT
| Catalent Inc | Pnjgqcxk | Lbsjz | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Rnrljxbd | Cbpv | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Yhypmdy | Qtck | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Sfvhrvmcz | Dthxsl | $3.5 Bil |